Difference between revisions of "Part:BBa K4429010"

 
 
Line 3: Line 3:
 
<partinfo>BBa_K4429010 short</partinfo>
 
<partinfo>BBa_K4429010 short</partinfo>
  
−
-
+
NeoFvs are engineered antibody fragments. An scFv is defined as the variable domains of a full length antibody connected via a flexible linker. A NeoFv is a name given by iGEM 2022 team IISER-Pune2_India to scFvs with a small peptide extension that binds to the human neonatal Fc receptor (or FcRn receptor). Such scFvs with an FcRn binding peptide have recently been described in literature[1] with potential to overcome the size problem of scFvs, and extend their half life of circulation in the human body.
 +
 
 +
NeoFv C10 VH-VL-LinY12H is one such NeoFv derived from the C10 antibody targeting the envelope-dimer epitope of the Dengue virus. A NeoFv derived from C10 can ideally be a therapy for Dengue fever.
  
 
<!-- Add more about the biology of this part here
 
<!-- Add more about the biology of this part here
Line 17: Line 19:
 
<partinfo>BBa_K4429010 parameters</partinfo>
 
<partinfo>BBa_K4429010 parameters</partinfo>
 
<!-- -->
 
<!-- -->
 +
 +
===References===
 +
*1]Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments
 +
Vince W. Kelly and Shannon J. Sirk
 +
ACS Chemical Biology 2022 17 (2), 404-413
 +
DOI: 10.1021/acschembio.1c00862

Latest revision as of 03:29, 14 October 2022


NeoFv C10 VH-VL-LinY12H

NeoFvs are engineered antibody fragments. An scFv is defined as the variable domains of a full length antibody connected via a flexible linker. A NeoFv is a name given by iGEM 2022 team IISER-Pune2_India to scFvs with a small peptide extension that binds to the human neonatal Fc receptor (or FcRn receptor). Such scFvs with an FcRn binding peptide have recently been described in literature[1] with potential to overcome the size problem of scFvs, and extend their half life of circulation in the human body.

NeoFv C10 VH-VL-LinY12H is one such NeoFv derived from the C10 antibody targeting the envelope-dimer epitope of the Dengue virus. A NeoFv derived from C10 can ideally be a therapy for Dengue fever.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


References

  • 1]Short FcRn-Binding Peptides Enable Salvage and Transcytosis of scFv Antibody Fragments

Vince W. Kelly and Shannon J. Sirk ACS Chemical Biology 2022 17 (2), 404-413 DOI: 10.1021/acschembio.1c00862